-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Black Diamond Therapeutic, Lowers Price Target to $8

Benzinga·01/16/2026 16:11:34
Listen to the news
Piper Sandler analyst Kelsey Goodwin maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Overweight and lowers the price target from $9 to $8.